Following the inspection, the facility received one observation in Form 483. Cipla stated its commitment to working closely with the FDA to address the observation comprehensively within the ...

Restricted patients told us they understood they could be restricted when detained under the Mental Health Act ... recording the level of observation with no detail or signature of which staff ...

Johnson & Johnson on Monday said it has agreed to acquire Intra-Cellular Therapies, a developer of drugs for diseases of the brain, for $132 per share, or about $14.6 billion. The announcement of the ...